PlainPharmaWatch

CMS Open Payments · Program Year 2024

60 Degrees Pharmaceuticals

60 Degrees Pharmaceuticals reported $109,563.25 across General Payments, Research, and Ownership to 10 physicians and teaching hospitals across 13 transactions.

See the rankings → How this is sourced
$109.6K
All-tracks total
13
Transactions
10
Recipients
#1159
of 1,925 companies

60 Degrees Pharmaceuticals reported $109,563.25 across all CMS Open Payments tracks (General + Research + Ownership) to 10 physicians and teaching hospitals in Program Year 2024 - ranking #1159 of 1,925 reporting manufacturers (0.0% of the all-tracks industry total); General Payments alone were $5,230.50, averaging $11.0K per recipient.

Data currency: Figures are rendered from the processed CMS Open Payments release. See our methodology for source dates and refresh cadence. Spot a figure that looks wrong? Report a correction.

Compiled from official public sources by the publisher.

CMS Sunshine Act warrant

Manufacturer 60-degrees-pharmaceuticals 60 Degrees Pharmaceuticals

$109.6K · #1159/1,925 · 0.0% industry · PY2024

  • TOT $109.6K
  • RANK #1159
  • SHARE 0.0%
  • TXN 13
  • RCP 10
  • CAT 2
  • GEN $5.2K
  • TOP1 24.6%
  • PY 2024

Volume peers

Nearest volume peer: Elevate Oral Care ($109.5K)

Atos Medical Inc$110.5K60 Degrees Pharmaceuticals (…$109.6KElevate Oral Care$109.5KVisionix USA, Inc$108.9KSirona Dental Systems GmbH$108.6K
All-tracks payment totals near 60 Degrees Pharmaceuticals (CMS Open Payments PY2024)

60 Degrees Pharmaceuticals sits among 1,925 manufacturers disclosing under the Physician Payments Sunshine Act. Volume peers below are nearest by all-tracks total, not corporate affiliates. Open the company rankings →

What the Data Shows for 60 Degrees Pharmaceuticals

Rank #1159 of 1,925 companies in CMS Open Payments for 2024 belongs to 60 Degrees Pharmaceuticals, which reported $109,563.25 across 13 transactions to 10 recipients - a comparatively small 0.0% slice of all industry payments reported nationwide for the year. Averages work out to $8.4K per transaction and $11.0K per recipient.

"Consulting Fee" leads the 2-category general-payment breakdown below at $4.8K (91.8% of General Payments, 5 transactions) - see our methodology for how research and ownership payments are reported separately.

General Payment Breakdown by Type

60 Degrees Pharmaceuticals made 2 types of general payments. "Consulting Fee" is the largest category at $4.8K, 91.8% of General Payments.

How 60 Degrees Pharmaceuticals divides its payments

General-payment categories, ordered by reported total

1. Consulting Fee$4.8K2. Food and Beverage$430.50
Payment Type Amount Transactions
Consulting Fee $4.8K 5
Food and Beverage $430.50 5

Recipient Concentration in General Payments

The five largest recipient relationships account for $5,230.50 (100.0%) of $5,230.50 in this company's General Payments records across 5 recipients.

General Payments scope note

Program Year 2024 General Payments view only: excludes research and ownership/investment records, so it is not the all-category company total above.

Largest General-Payment relationships for 60 Degrees Pharmaceuticals

The five named recipients with the highest reported General Payments from this company

Thomas Moorcroft$1.3KVirginia Savely$986.10Shannon Delaney$986.10Denis Bouboulis$986.10Richard Horowitz$986.10
  1. 1

    Thomas Moorcroft

    $1,286.10 across 2 reported transactions

  2. 2

    Virginia Savely

    $986.10 across 2 reported transactions

  3. 3

    Shannon Delaney

    $986.10 across 2 reported transactions

  4. 4

    Denis Bouboulis

    $986.10 across 2 reported transactions

  5. 5

    Richard Horowitz

    $986.10 across 2 reported transactions

Compare this company's payment profile with similarly sized manufacturers in the company comparison tool, and consult the methodology for the CMS source scope.

Similarly Concentrated Companies

Companies whose General Payments are spread across recipients about as (un)evenly as 60 Degrees Pharmaceuticals's, measured by the same HHI concentration index above, not by payment size.

What HHI 2,500 means here

2,500 is the DOJ/FTC merger-guidelines threshold for "highly concentrated" markets; used here only as a familiar concentration reference, not a legal finding about 60 Degrees Pharmaceuticals.

iSchemaView, Inc.

HHI 2026

GastroKlenz, Inc. DBA CloudCath

HHI 2028

ZSFab, Inc.

HHI 2031

Pharmaceutical Business Consultants Limited

HHI 2034

Companies with Similar Payment Volumes

Open a profile or compare a similar company's CMS-reported payment pattern with 60 Degrees Pharmaceuticals.

Showing 6 of 1,924 companies with CMS-reported payment data.

Data Source: Centers for Medicare & Medicaid Services (CMS) Open Payments, Program Year 2024. Data includes general payments, research payments, and physician ownership/investment interests as required by the Physician Payments Sunshine Act. Total industry payments: $13.9B across 1,925 companies.

Data sourced from CMS Open Payments (Physician Payments Sunshine Act). See our methodology for details. Retrieved and formatted by PlainPharmaWatch
Disclaimer

This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the CMS Open Payments program. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

View saved (companies)
Download 60 Degrees Pharmaceuticals's data (CSV)
Embed this widget

Copy this snippet to embed a live-linked card on your own site.

Every figure on PlainPharmaWatch is rendered directly from federal source data, no number is typed in by an editor. This page draws directly on federal source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of 2026-07-26.